Twist Bioscience Corporation (TWST)
NASDAQ: TWST · Real-Time Price · USD
32.95
+2.13 (6.91%)
At close: May 12, 2025, 4:00 PM
33.40
+0.45 (1.37%)
After-hours: May 12, 2025, 6:17 PM EDT
Twist Bioscience Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Twist Bioscience stock have an average target of 49.1, with a low estimate of 33 and a high estimate of 62. The average target predicts an increase of 49.01% from the current stock price of 32.95.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Twist Bioscience stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $55 → $48 | Strong Buy | Maintains | $55 → $48 | +45.68% | May 6, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $50 | Strong Buy | Reiterates | $50 | +51.75% | May 6, 2025 |
| Baird | Baird | Buy Maintains $54 → $44 | Buy | Maintains | $54 → $44 | +33.54% | May 6, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $40 → $33 | Sell | Maintains | $40 → $33 | +0.15% | May 6, 2025 |
| Barclays | Barclays | Buy Maintains $58 → $45 | Buy | Maintains | $58 → $45 | +36.57% | Apr 10, 2025 |
Financial Forecast
Revenue This Year
383.53M
from 312.97M
Increased by 22.54%
Revenue Next Year
451.69M
from 383.53M
Increased by 17.77%
EPS This Year
-2.21
from -3.60
EPS Next Year
-1.71
from -2.21
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 396.8M | 476.6M | 584.9M | ||
| Avg | 383.5M | 451.7M | 534.2M | ||
| Low | 365.3M | 418.5M | 489.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.8% | 24.3% | 29.5% | ||
| Avg | 22.5% | 17.8% | 18.3% | ||
| Low | 16.7% | 9.1% | 8.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.89 | -1.25 | -0.78 |
| Avg | -2.21 | -1.71 | -1.31 |
| Low | -2.77 | -2.40 | -2.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.